Preimplantation Genetic Diagnosis Cost (PGTA Test Cost)

What is the Preimplantation Genetic Diagnosis/ Testing Cost in India?

Preimplantation genetic testing is expensive since it requires conducting an embryo biopsy and genetic testing on the embryo. Being a relatively new process, the PGT test cost of embryos is usually not covered by insurance, which makes it quite costly for a patient. When genetic testing is prescribed by a fertility doctor, health insurance policies often cover the associated costs. It is recommended to discuss the cost after having your case assessed by the doctor because the PGT-A price has a set as well as a variable component dependent on the number of blastocysts generated.

Preimplantation genetic diagnosis costs (pgta costs) are determined per embryo by genetic laboratories. The expense increases as the number of embryos that must be tested increases.

Factors Affecting PGT-A Test Cost

The cost of PGT-A testing might also differ significantly from patient to patient. The frequency of IVF cycles needed, including egg extraction, fertilisation, testing, and embryo transfer, the number of embryos to test, the genetic disease's inheritance pattern, and the equipment needed for PGT-A testing at each facility are all variables that might affect the procedure cost. The cost of preimplantation genetic testing increases if more tests are required or if several family members must be tested in order to get a significant result.

To get the most precise findings, the top-class PGT laboratory at Indira IVF always develops a customised test for each patient. The price of the test is affected by the kind of disease, the technology being employed, and the structure of the family. For the majority of tests, the test's design requires DNA samples from the couple's parents or other family members. The preimplantation genetic testing cost also differs based on your age and the number of embryos you have.

Indira IVF is dedicated to staying abreast of the most recent developments in genetics and the human reproductive system and making them accessible to couples who are denied the opportunity to become parents.